Vimarsana
Biggest News Aggregation in the World

Page 3 - Biofoundry Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biofoundry Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biofoundry Services Today - Breaking & Trending Today

Financial Review: Codex DNA (DNAY) and Its Rivals - Vimarsana News

Financial Review: Codex DNA (DNAY) and Its Rivals

Codex DNA (NASDAQ:DNAY – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it compare to its competitors? We will compare Codex DNA to related companies based on the strength of its dividends, analyst recommendations, valuation, profitability, risk, earnings and institutional ownership. Institutional & Insider Ownership 87.6% of […]

Nautilus Biotechnology (NASDAQ:NAUT) versus Codex DNA (NASDAQ:DNAY) Financial Survey - Vimarsana News

Nautilus Biotechnology (NASDAQ:NAUT) versus Codex DNA (NASDAQ:DNAY) Financial Survey

Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) and Codex DNA (NASDAQ:DNAY – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Profitability This table compares Nautilus Biotechnology and Codex DNA’s […]

Comparing Codex DNA (DNAY) and Its Competitors - Vimarsana News

Comparing Codex DNA (DNAY) and Its Competitors

Codex DNA (NASDAQ:DNAY – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Codex DNA to similar companies based on the strength of its valuation, analyst recommendations, profitability, risk, institutional ownership, dividends and earnings. Profitability This table compares Codex DNA […]

Codex DNA (NASDAQ:DNAY) Upgraded by Zacks Investment Research to "Hold" - Vimarsana News

Codex DNA (NASDAQ:DNAY) Upgraded by Zacks Investment Research to "Hold"

Codex DNA (NASDAQ:DNAY – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Codex DNA Inc. is a creator of the BioXp(TM) system, a fully automated benchtop instrument which enables numerous synthetic biology workflows. Codex DNA Inc. […]

Head to Head Survey: Cue Health (NASDAQ:HLTH) versus Codex DNA (NASDAQ:DNAY) - Vimarsana News

Head to Head Survey: Cue Health (NASDAQ:HLTH) versus Codex DNA (NASDAQ:DNAY)

Cue Health (NASDAQ:HLTH – Get Rating) and Codex DNA (NASDAQ:DNAY – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends. Profitability This table compares Cue Health and Codex DNA’s […]